Uppsala Monitoring Centre

Profile narrative

Uppsala Monitoring Centre (UMC) operates the WHODrug and Vigi families of platforms, which include VigiFlow, VigiLyze, WHODrug Insight, Vaccine eReporting, primary eReporting and associated user access portals. These systems are designed to support drug monitoring and safety activities by collecting, managing and analysing adverse reaction information. The organisation delivers these services to a range of organisations that rely on its tools for pharmacovigilance work. Its headquarters are located in Sweden. The platforms are accessed via online portals that enable users to submit, retrieve and evaluate safety data.

UMC’s distinguishing attribute is its specialisation in pharmacovigilance, where it provides standardized tools that facilitate the detection and assessment of adverse drug reactions across different jurisdictions. In January 2024, a cyber attack on its IT provider Tietoevry disrupted these services, leading to outages in several core components while Vaccine eReporting and primary eReporting functions were restored. UMC responded by activating a crisis team to coordinate recovery and communicate updates. The incident was investigated without finding evidence of data compromise. The event highlighted the critical dependence of its stakeholders on the continuous availability of its monitoring platforms.

Incidents

1 incident linked to this organisation.